Access to anti-retroviral drugs, female in Middle East, North Africa, Afghanistan & Pakistan
Middle East, North Africa, Afghanistan & Pakistan: Access to anti-retroviral drugs, female was 39.7% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Middle East, North Africa, Afghanistan & Pakistan, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Middle East, North Africa, Afghanistan & Pakistan recorded 39.7% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
That represents a change of up 5.2% on the previous year and up 89.3% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Middle East, North Africa, Afghanistan & Pakistan peaked at 39.7% in 2024 and was at its lowest, 1.9%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Middle East, North Africa, Afghanistan & Pakistan, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 1.9% | — |
| 2001 | 2.3% | +17.7% |
| 2002 | 2.6% | +13.3% |
| 2003 | 5.4% | +108.7% |
| 2004 | 4.7% | -12.3% |
| 2005 | 5.8% | +22.0% |
| 2006 | 6.8% | +17.1% |
| 2007 | 7.9% | +16.3% |
| 2008 | 9.0% | +14.8% |
| 2009 | 10.9% | +20.2% |
| 2010 | 12.8% | +17.8% |
| 2011 | 14.0% | +9.7% |
| 2012 | 16.4% | +17.1% |
| 2013 | 18.3% | +11.6% |
| 2014 | 21.0% | +14.4% |
| 2015 | 22.8% | +8.5% |
| 2016 | 25.3% | +11.3% |
| 2017 | 27.5% | +8.6% |
| 2018 | 30.0% | +9.1% |
| 2019 | 31.4% | +4.5% |
| 2020 | 31.5% | +0.5% |
| 2021 | 34.2% | +8.6% |
| 2022 | 35.1% | +2.6% |
| 2023 | 37.8% | +7.4% |
| 2024 | 39.7% | +5.2% |
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, female in Middle East, North Africa, Afghanistan & Pakistan changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2003 | +108.7% | 2.6% | 5.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.7% | 1.9% | 10.9% | 10 |
| 2010s | 22.0% | 12.8% | 31.4% | 10 |
| 2020s | 35.7% | 31.5% | 39.7% | 5 |
Countries ranked near Middle East, North Africa, Afghanistan & Pakistan
More gender data for Middle East, North Africa, Afghanistan & Pakistan
- Labor force, female 53.25 million (2025)
- Labor force, female, per capita 0.0643 units per person (2025)
- Labor force, female, per unit of GDP 0 units per US$ of GDP (2025)
- Labor force, female, annual growth rate 2.39 % change on previous year (2025)
- Labor force, female, per square kilometre 4.05 units per square kilometre (2023)
- Ratio of female to male youth unemployment rate (% ages 15-24) 170.9% (2025)
- School life expectancy, primary to tertiary, female 13.02 years (2018)
- School life expectancy, primary to tertiary, male 13.36 years (2018)
- Proportion of women in ministerial level positions 13.5% (2025)
- Own-account workers, female (% of female employment) 13.1% (2016)
All data for Middle East, North Africa, Afghanistan & Pakistan →
Frequently asked questions
- What is access to anti-retroviral drugs, female in Middle East, North Africa, Afghanistan & Pakistan?
- Access to anti-retroviral drugs, female in Middle East, North Africa, Afghanistan & Pakistan was 39.7% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Middle East, North Africa, Afghanistan & Pakistan?
- The highest recorded value was 39.7% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Middle East, North Africa, Afghanistan & Pakistan?
- The lowest recorded value was 1.9% in 2000.
- How does Middle East, North Africa, Afghanistan & Pakistan rank for access to anti-retroviral drugs, female?
- Middle East, North Africa, Afghanistan & Pakistan ranks 17th out of 19 groups with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Middle East, North Africa, Afghanistan & Pakistan?
- Over the last ten years it is up 89.3%. The long-run trend across the full record is volatile.
- Where does this Middle East, North Africa, Afghanistan & Pakistan data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.